KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks

Range Low Price High Price Comment
30 days $0.140 $0.285 Wednesday, 17th Aug 2022 EYEG stock ended at $0.141. This is 5.37% less than the trading day before Tuesday, 16th Aug 2022. During the day the stock fluctuated 4.29% from a day low at $0.140 to a day high of $0.146.
90 days $0.140 $0.640
52 weeks $0.140 $2.34

Historical Eyegate Pharmaceuticals prices

Date Open High Low Close Volume
Jan 29, 2016 $1.75 $1.77 $1.69 $1.70 13 900
Jan 28, 2016 $1.63 $1.83 $1.63 $1.69 5 700
Jan 27, 2016 $1.76 $1.84 $1.62 $1.70 10 600
Jan 26, 2016 $1.60 $1.70 $1.60 $1.69 16 300
Jan 25, 2016 $1.77 $1.77 $1.67 $1.70 8 100
Jan 22, 2016 $1.82 $1.88 $1.60 $1.76 24 600
Jan 21, 2016 $1.56 $1.62 $1.56 $1.62 1 300
Jan 20, 2016 $1.73 $1.73 $1.38 $1.65 35 900
Jan 19, 2016 $1.77 $1.85 $1.45 $1.59 44 600
Jan 15, 2016 $1.74 $1.74 $1.59 $1.74 17 100
Jan 14, 2016 $1.69 $1.74 $1.44 $1.74 61 600
Jan 13, 2016 $2.00 $2.10 $1.60 $1.63 76 900
Jan 12, 2016 $2.14 $2.25 $2.00 $2.05 68 000
Jan 11, 2016 $2.58 $2.62 $2.00 $2.04 179 300
Jan 08, 2016 $2.62 $2.62 $2.17 $2.37 72 300
Jan 07, 2016 $2.73 $2.73 $2.51 $2.52 16 500
Jan 06, 2016 $2.60 $2.79 $2.52 $2.69 157 300
Jan 05, 2016 $2.61 $2.74 $2.60 $2.74 20 000
Click to get the best stock tips daily for free!

About Eyegate Pharmaceuticals

Eyegate Pharmaceuticals Eyegate Pharmaceuticals, Inc., a clinical-stage specialty pharmaceutical company, focuses on developing and commercializing therapeutics and drug delivery systems for treating eye diseases. The company is developing EGP-437 that has completed Phase III clinical trials in anterior uveitis for the treatment of various inflammatory conditions of the eye, including uveitis, a debilitating form of intraocular inflammation of the anterior portion of th... EYEG Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT